TD Cowen analyst Ritu Baral maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a price target of ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

The rating changes comes after Wednesday’s release of “in-line and mixed” fourth-quarter 2024 financial results, which saw it ...

Microsoft has walked away from some of its commitments with cloud computing provider CoreWeave in a significant blow to a company seeking to launch a blockbuster $35bn initial public offering next ...

Investment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.

Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...

Amgen (NASDAQ:AMGN) has announced the beginning of two Phase 3 studies for its weight loss candidate MariTide as the company ...

Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...

We recently compiled a list of the 10 Best Performing Fintech Stocks to Buy According to Analysts. In this article, we are ...

In a report released today, Brendan Smith from TD Cowen maintained a Buy rating on Repligen (RGEN – Research Report), with a price target of ...

Calumet downgraded at TD Cowen, saying the market has more fully accounted for near-term risks both for the Montana Renewable ...